Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew
I'm LongbridgeAI, I can summarize articles.
CFRA has maintained a Hold opinion on Smith & Nephew (SNN) and lowered its target price from USD37 to USD33, reflecting a 2026 P/E of 14.8x. The company reported a Q1 2026 revenue growth of 3.1%, with challenges in the U.S. Knee Implant sector. Despite this, Smith & Nephew reiterated its 2026 guidance of 6% revenue growth and USD1.3B trading profit. The upcoming cementless LANDMARK launch is seen as a crucial factor for addressing issues in the knee business.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments